Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic.
Highlights
The COVID-19 pandemic has been classified as a global health emergency by the World Health Organization (WHO).[1]
The presence of poor glycemic control both in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) is associated with higher mortality from COVID-19.5 Obesity has been identified as an important risk factor for morbidity, and there is a correlation between body mass index (BMI) and poor clinical outcomes, such as need for mechanical ventilation or death, as seen in Figures 4(a) and (b)
The screening clinic is only for the patients who have symptoms or had contact with COVID-19 patients. From our analysis of the data released by the National Health Insurance System (NHIS), we discovered that diabetes patients have a 1.5- to 2.0-fold increased risk for death, oxygen therapy, and intensive care unit (ICU) care. COVID-19 patients in severe condition are being treated with supportive care with remdesivir and convalescent plasma (CP) transfusion therapy
Summary
The COVID-19 pandemic has been classified as a global health emergency by the World Health Organization (WHO).[1]. The participants were experts in COVID-19 and/or diabetes. The meeting was divided into five sessions, which included keynote presentations as one of the sessions, plus four additional sessions, which each contained two parts. The meeting’s eight parts were divided into 24 sections, each consisting of presentations by a set of experts and a panel discussion. This meeting report summarizes the Key Points of each speaker and the major themes discussed by the panels in each of the 24 sections of the meeting. Many speakers pointed out a very recent trend in healthcare, precipitated by the COVID-19 pandemic, for patients and the healthcare system to interact by way of electronic communication tools.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
